Tuesday, July 30, 2024 5:21:33 PM
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations
Recent PASG News
- Passage Bio Welcomes Tom Kassberg to Board of Directors • GlobeNewswire Inc. • 09/10/2024 11:52:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 11:00:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:11 PM
- Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/30/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/09/2024 09:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:00:22 AM
- Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Passage Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:00:47 AM
- Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:01:19 AM
- Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
- Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/05/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:52:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:03:29 PM
- Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2024 12:15:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 11:15:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:01:06 AM
- Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program • GlobeNewswire Inc. • 03/05/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/04/2024 10:22:12 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM